- Report
- July 2025
- 149 Pages
From €3061EUR$3,450USD£2,672GBP
- Report
- August 2024
- 211 Pages
Global
From €3948EUR$4,450USD£3,446GBP
- Report
- February 2024
- 160 Pages
Global
From €4408EUR$4,969USD£3,848GBP
- Report
- July 2024
- 155 Pages
Global
From €3205EUR$3,613USD£2,798GBP
€3771EUR$4,250USD£3,291GBP
- Report
- March 2020
- 49 Pages
Global
€1169EUR$1,318USD£1,021GBP
- Report
- September 2022
- 154 Pages
Global
From €1774EUR$2,000USD£1,549GBP
- Report
- August 2024
- 80 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- August 2024
- 79 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- May 2023
- 105 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- April 2023
- 104 Pages
Global
From €3500EUR$4,226USD£3,162GBP
- Report
- March 2024
- 132 Pages
Global
From €843EUR$950USD£736GBP
The Anti Diarrheal market is a subset of the Gastrointestinal Drugs market, which includes medications used to treat a variety of gastrointestinal disorders. Anti Diarrheal drugs are used to treat diarrhea, which is a common symptom of many gastrointestinal disorders. These drugs work by reducing the amount of water and electrolytes lost in the stool, and by slowing down the movement of the intestines. Commonly used Anti Diarrheal drugs include loperamide, diphenoxylate, and bismuth subsalicylate.
The Anti Diarrheal market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, Johnson & Johnson, and Novartis. Other companies in the market include Sanofi, Bayer, AstraZeneca, and Daiichi Sankyo. Show Less Read more
